Wikidata entity: Q66026501
Quantities
| P4135 | maximum age | 65 |
| P2899 | minimum age | 13 |
| P1132 | number of participants | 40 |
| P6099 | clinical trial phase | ... | Q42825046 (phase IV clinical trial) | phase IV clinical trial |
| P17 | country | ... | Q865 (Taiwan) | Taiwan |
| P31 | instance of | ... | Q30612 (clinical trial) | clinical trial |
| P4844 | research intervention | ... | Q32089 (sirolimus) | sirolimus |
| P6153 | research site | ... | Q1418766 (National Taiwan University Hospital) | National Taiwan University Hospital |
| P859 | sponsor | ... | Q1418766 (National Taiwan University Hospital) | National Taiwan University Hospital |
| P580 | start time | ... | 2002-09-01 | ??? |
| P8363 | study type | ... | Q78089383 (interventional study) | interventional study |
| P1476 | title | Monolingualtext | Effects of Conversion From Sirolimus Oral Solution to Tablets in Renal Transplant Recipients. | ??? |
| P3098 | ClinicalTrials.gov ID | NCT00166842 |
Why not click here or view trends?
log id: 4859980